Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Pulmonx Corporation

< Previous 1 2 Next >
Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial
From Pulmonx Corporation
Via Business Wire
Tickers LUNG
Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results
From Pulmonx Corporation
Via GlobeNewswire
Tickers LUNG
Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer
From Pulmonx Corporation
Via GlobeNewswire
Tickers LUNG
Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024
From Pulmonx Corporation
Via GlobeNewswire
Tickers LUNG
Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference
From Pulmonx Corporation
Via GlobeNewswire
Tickers LUNG
Pulmonx to Participate at Upcoming Investor Conferences
From Pulmonx Corporation
Via GlobeNewswire
Tickers LUNG
Pulmonx Reports Record Third Quarter 2023 Financial Results
From Pulmonx Corporation
Via GlobeNewswire
Tickers LUNG
Pulmonx to Report Third Quarter 2023 Financial Results on October 30, 2023
From Pulmonx Corporation
Via GlobeNewswire
Tickers LUNG
Pulmonx Announces CFO Transition and Record Preliminary Third Quarter 2023 Revenue
From Pulmonx Corporation
Via GlobeNewswire
Tickers LUNG
Pulmonx to Participate at Upcoming Investor Conferences
From Pulmonx Corporation
Via GlobeNewswire
Tickers LUNG
Pulmonx Reports Second Quarter 2023 Financial Results
From Pulmonx Corporation
Via GlobeNewswire
Tickers LUNG
Pulmonx to Present at the Canaccord Genuity 43rd Annual Growth Conference
From Pulmonx Corporation
Via GlobeNewswire
Tickers LUNG
Pulmonx to Report Second Quarter 2023 Financial Results on August 2, 2023
From Pulmonx Corporation
Via GlobeNewswire
Tickers LUNG
Pulmonx Reports First Quarter 2023 Financial Results
From Pulmonx Corporation
Via GlobeNewswire
Tickers LUNG
Pulmonx to Present at the Bank of America Securities 2023 Health Care Conference
From Pulmonx Corporation
Via GlobeNewswire
Tickers LUNG
Pulmonx to Report First Quarter 2023 Financial Results on May 2, 2023
From Pulmonx Corporation
Via Business Wire
Tickers LUNG
Pulmonx Reports Fourth Quarter and Full Year 2022 Financial Results
From Pulmonx Corporation
Via GlobeNewswire
Tickers LUNG
Pulmonx to Present at the Citi 2023 Healthcare Conference
From Pulmonx Corporation
Via GlobeNewswire
Tickers LUNG
Pulmonx to Report Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023
From Pulmonx Corporation
Via GlobeNewswire
Tickers LUNG
American Lung Association Campaign Shines Spotlight on Endobronchial Valves for Advanced COPD/Emphysema
From Pulmonx Corporation
Via Business Wire
Tickers LUNG
Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema
From Pulmonx Corporation
Via Business Wire
Tickers LUNG
Pulmonx to Present at the 34th Annual Piper Sandler Healthcare Conference
From Pulmonx Corporation
Via GlobeNewswire
Tickers LUNG
Pulmonx to Participate at Upcoming Investor Conferences
From Pulmonx Corporation
Via GlobeNewswire
Tickers LUNG
Pulmonx Reports Third Quarter 2022 Financial Results
From Pulmonx Corporation
Via GlobeNewswire
Tickers LUNG
Pulmonx to Report Third Quarter 2022 Financial Results on November 3, 2022
From Pulmonx Corporation
Via GlobeNewswire
Tickers LUNG
ADDING and REPLACING CONVERT Clinical Trial Data Presented at ERS Demonstrates Early Success of AeriSeal System in Patients with Advanced COPD/Emphysema
From Pulmonx Corporation
Via Business Wire
Tickers LUNG
Pulmonx to Present at Upcoming September Investor Conferences
From Pulmonx Corporation
Via Business Wire
Tickers LUNG
Pulmonx to Present at the Canaccord Genuity 42nd Annual Growth Conference
From Pulmonx Corporation
Via Business Wire
Tickers LUNG
Pulmonx to Report Second Quarter 2022 Financial Results on August 2, 2022
From Pulmonx Corporation
Via Business Wire
Tickers LUNG
Pulmonx Announces Two Additional Significant Blue Cross Blue Shield Plans Now Provide Coverage for Severe Emphysema/COPD Treatment
From Pulmonx Corporation
Via Business Wire
Tickers LUNG
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.